Breastcancer.org
Jane Hollingsworth is a prominent figure in the biotechnology and life sciences sectors, currently serving as Co-Founder and Executive Chair at Eliksa Therapeutics and Spirovant Sciences, and holding leadership roles at CervoMed, RIBONOVA INC., Afimmune Ltd., and Militia Hill Ventures. With extensive experience on various boards, including Breastcancer.org and the University City Science Center, Jane focuses on advancing innovative medical solutions for rare diseases and improving patient outcomes. Jane's educational background includes a Doctor of Law (J.D.) from Villanova University and a Bachelor of Arts (B.A.) from Gettysburg College.
This person is not in any teams
This person is not in any offices
Breastcancer.org
1 followers
We are a nonprofit organization dedicated to helping women, men, and their loved ones make sense of the complex medical and personal information about breast health and breast cancer, so they can make the best decisions for their lives.